HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Béatrice Mahé Selected Research

Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)

12/2008Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Béatrice Mahé Research Topics

Disease

5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2022 - 01/2017
5Multiple Myeloma
01/2021 - 11/2011
4Neoplasms (Cancer)
01/2024 - 12/2008
4Waldenstrom Macroglobulinemia (Macroglobulinemia)
10/2023 - 11/2011
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 09/2005
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024 - 04/2021
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2019
2Lymphoma (Lymphomas)
01/2021 - 01/2019
1Pathologic Complete Response
01/2023
1Disease Progression
06/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019
1Hodgkin Disease (Hodgkin's Disease)
01/2019
1Leukemia
01/2019
1Neutropenia
02/2018
1Infections
02/2018
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2012
1Monoclonal Gammopathy of Undetermined Significance
11/2011
1Hemorrhage
11/2011
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2008
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2008
1Zygomycosis (Phycomycosis)
02/2005
1Hematologic Diseases (Blood Diseases)
02/2005

Drug/Important Bio-Agent (IBA)

9Rituximab (Mabthera)FDA Link
10/2023 - 12/2008
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023 - 01/2018
3Dexamethasone (Maxidex)FDA LinkGeneric
10/2023 - 11/2017
3fludarabineIBA
01/2023 - 01/2018
2Bortezomib (Velcade)FDA Link
10/2023 - 11/2017
2obinutuzumabIBA
01/2023 - 11/2021
2Proteasome InhibitorsIBA
06/2019 - 06/2019
2Monoclonal AntibodiesIBA
06/2019 - 12/2008
2flt3 ligand protein (flt3 ligand)IBA
01/2019 - 01/2019
1Interleukin-2 (IL2)IBA
01/2024
1Zoledronic Acid (Zometa)FDA Link
01/2024
1ibrutinibIBA
01/2023
1idelalisibIBA
11/2021
1LigandsIBA
01/2021
1KIR ReceptorsIBA
01/2021
1CytokinesIBA
01/2021
1dabrafenibIBA
07/2020
1trametinibIBA
07/2020
1Lenalidomide (CC 5013)FDA Link
06/2019
1daratumumabIBA
06/2019
1pomalidomideIBA
06/2019
1Fluorine-18IBA
01/2019
1Alemtuzumab (Campath)FDA Link
01/2018
1Hemoglobins (Hemoglobin)IBA
08/2012
1Immunoglobulin G (IgG)IBA
11/2011
1Immunoglobulin A (IgA)IBA
11/2011
1von Willebrand FactorIBA
11/2011
1Immunoglobulin M (IgM)IBA
11/2011
1Hemostatics (Antihemorrhagics)IBA
11/2011
1Factor VIII (Coagulation Factor VIII)IBA
11/2011
1InterferonsIBA
12/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2008
1epoetin betaIBA
01/2008
1ErythropoietinFDA Link
01/2008
1Mitoxantrone (Novantrone)FDA LinkGeneric
09/2005
1Gemtuzumab (Mylotarg)FDA Link
09/2005
1Voriconazole (Vfend)FDA LinkGeneric
02/2005

Therapy/Procedure

5Therapeutics
06/2022 - 06/2019
3Drug Therapy (Chemotherapy)
10/2023 - 09/2005
1Immunotherapy
01/2021
1Homologous Transplantation
01/2019
1Hematopoietic Stem Cell Transplantation
01/2019
1Stem Cell Transplantation
01/2019